Mechanistically, we provided evidence that WDR4 is transcriptionally activated by c-MYC (MYC), facilitates cell proliferation and metastasis, and enhances sorafenib resistance by promoting CCNB1 translation in HCC. The gene discussed is CCNB1; the disease is hepatocellular carcinoma.